Not applicableStudy completedNCT02402699
What this trial is testing
Ipilimumab 60-month Pharmacovigilance Protocol for Advanced Melanoma Patients Who Are Hepatitis B and/or Hepatitis C Virus Positive in Taiwan
Who this might be right for
Advanced MelanomaHepatitis BHepatitis C
Bristol-Myers Squibb 3